ArticleJournal of gastrointestinal oncology2021

A dual-targeted molecular therapy of PP242 and cetuximab plays an anti-tumor effect through EGFR downstream signaling pathways in colorectal cancer.

Linghui Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.